Infection Prevention and Epidemiology
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease Control and Prevention Aug. 8. Wastewater levels for COVID-19 have been classified as moderate nationwide, with the highest detected in the…
Ochsner Health's Stephen Saenz, sepsis program manager, and Teresa Arrington, director of robust process improvement for quality and patient safety, reveal how a mix of smart technology, clinician-led design and flexible implementation reduced sepsis-related mortality by 20% across its health…
The Centers for Disease Control and Prevention Dec. 18 announced that a patient in Louisiana was hospitalized with a severe case of H5N1 bird flu, the first known instance of severe infection in the U.S.
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued decreases in hospitalizations last year.
A tool designed for EVS workers to find resources/trainings aligned with AHE's competencies in order to identify resources across all job levels.
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1 bird flu, as two human cases only showed symptoms of conjunctivitis before confirmation.
Recent research findings, authored in part by UW Medicine, showed that during western Washington’s 2022 mpox outbreak, emergency response teams were highly accurate at identifying suspected mpox and providing same-day care.
The White House April 16 released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other nations and stakeholders.
FDA last month approved a new long-acting monoclonal antibody to prevent RSV in this age group.